Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients

Early diagnosis of invasive mould infections and disease

(2017) Frédéric Lamoth et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

Ten years of R&D and full automation in molecular diagnosis

(2016) Gilbert Greub et al.   Future Microbiology

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Combination Antifungal Therapy for Invasive Aspergillosis

(2015) Kieren A. Marr et al.   ANNALS OF INTERNAL MEDICINE

Serum Galactomannan-Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis

(2014) R. F. Duarte et al.   CLINICAL INFECTIOUS DISEASES

Performance of Serum Biomarkers for the Early Detection of Invasive Aspergillosis in Febrile, Neutropenic Patients: A Multi-State Model

(2013) Michaël Schwarzinger et al.   PLoS One

Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies

(2012) M. Reinwald et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases—the role of factors affecting assay performance

(2011) Zdenek Racil et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Accuracy of BAL Galactomannan in Diagnosing Invasive Aspergillosis

(2010) Ya-Ling Guo et al.   CHEST